The Kapyderm Ampoule System: N, KN, KD and DT — Which One, When, and Why
The Kapyderm Ampoule System:
N, KN, KD and DT — Which One, When, and Why
Four ampoules. Two families. One mechanism that separates them from every other leave-on scalp treatment on the market. The complete clinical guide to the Kapyderm ampoule system.
If you've ever felt a warming sensation when applying a scalp ampoule and wondered whether something was wrong — it wasn't. That warmth is the measurable, peer-reviewed confirmation that blood flow to your hair follicles has increased. It's called vasodilation, and understanding it is the key to understanding why Kapyderm ampoules work differently from every other scalp treatment on the market.
This guide covers all four Kapyderm Dermotricology ampoules — their full ingredient lists, clinical indications, the science behind each key active, how they compare to the leading professional competitors, and exactly when and how to use them.
The Kapyderm ampoule system divides into two families: the Purifying Ampoules (N and KN) and the Nutritive Reconstruction Ampoules (KD and DT). The key variable across three of the four is Methyl Nicotinate — the active that triggers localized scalp vasodilation via the prostaglandin D2 pathway, confirmed in peer-reviewed clinical research. This article covers every ampoule's full INCI, clinical indication, ingredient science, how it compares to Kérastase and Nioxin, and when to use each — for both home protocol users and certified Technicians of Dermotricology.
- Understanding the Ampoule System — Two Families
- The Key Variable: Methyl Nicotinate and Scalp Vasodilation
- The Purifying Family: Ampoule N and Ampoule KN
- The Nutritive Family: Ampoule KD and Ampoule DT
- Full Comparison: All Four Ampoules
- How Kapyderm Compares to Kérastase and Nioxin
- Ingredient Science: The Key Actives Explained
- Protocol Timeline: What to Expect Week by Week
- Protocol Placement: How the Ampoules Fit
- Frequently Asked Questions
Understanding the Ampoule System — Two Families
The four Kapyderm Dermotricology ampoules are not interchangeable. They are designed around two distinct therapeutic objectives — purification and nutrition — each with a specific place in the protocol and specific clinical indications. Understanding the system as a whole is the prerequisite for choosing correctly.
The two families are:
Purifying Family: Ampoule N and Ampoule KN — built on a botanical complex of burdock, arnica, rosemary, salicylic acid, sulfur and potassium iodide. Objective: clarify the follicular opening, eliminate sebum accumulation and oxidized byproducts, and prepare the scalp surface for subsequent active penetration. The single variable between them is Methyl Nicotinate — which KN contains and N does not.
Nutritive Reconstruction Family: Ampoule KD and Ampoule DT — built on a concentrated blend of Hydrolyzed Keratin, Sodium Hyaluronate, Calcium Pantothenate (B5), Pyridoxine HCl (B6), Cinchona bark extract and a botanical purifying complex. Objective: supply the follicle bulb with the structural proteins and growth-supporting nutrients it needs to extend the anagen phase, rebuild compromised hair fiber, and reactivate dormant follicle function. Both contain Methyl Nicotinate. The variable between them is the finishing active: Eucalyptol in KD, Menthol in DT.
Within the Dermotricology protocol developed by a certified Technician of Dermotricology (also referred to as a Dermotricologist, or dermotrichologist in clinical literature), ampoule selection is preceded by trichoscopy — the Kapykon Professional Scalp & Skin Analyzer maps the follicular environment at the microscopic level before any treatment begins. The trichoscopy findings determine which ampoule family is indicated, and whether Methyl Nicotinate activation is appropriate for the scalp presentation.
The four Kapyderm Dermotricology ampoules: Ampoule N (purifying, no warming), Ampoule KN (purifying + Methyl Nicotinate), Ampoule KD (nutritive reconstruction, Eucalyptol finish), Ampoule DT (nutritive reconstruction, Menthol finish).
The Key Variable: Methyl Nicotinate and Scalp Vasodilation
Three of the four ampoules contain Methyl Nicotinate (MN). Understanding what it does — and the confirmed mechanism by which it does it — is fundamental to understanding the Kapyderm ampoule system.
Methyl Nicotinate is a nicotinic acid ester. When applied topically to skin, it triggers a highly localized cutaneous vasodilatory response through the prostaglandin D2 pathway. A published clinical study using laser speckle contrast imaging (LSCI) confirmed the mechanism with precision: NSAID inhibition of cyclooxygenase-mediated prostaglandin synthesis reduced the MN-induced scalp perfusion increase by 82% (P < .01), while nerve pathway inhibition reduced it by 32% (P < .01) — confirming the prostaglandin pathway as the dominant mechanism.[1] Nicotinic acid derivatives stimulate mast cells to release prostaglandin D2, which then induces vasodilation, vascular permeability and increased blood flow at the application site.[1b]
Critically for the Kapyderm system: a landmark 1987 study in the British Journal of Dermatology (Bunker & Dowd) found no significant increase in scalp blood flow after epicutaneous application of 3% minoxidil to balding scalp — yet the same subjects did respond to 0.1% hexyl nicotinate, a closely related nicotinic acid ester.[1c] This direct comparison — nicotinate response where minoxidil produced none — establishes the scalp vasodilation mechanism of Methyl Nicotinate as clinically distinct and documented at the scalp level specifically, not only in forearm models.
The practical significance is this: when Methyl Nicotinate is present in the ampoule formula, the warming and redness the client feels is the biological confirmation that blood flow to the scalp has increased. The dermal microvasculature — including the capillary network that feeds the hair bulb and dermal papilla — has dilated. At that moment, every active ingredient in the ampoule has an enhanced delivery pathway to the follicle. The treatment is no longer sitting on the scalp surface; it is being driven toward the dermal papilla by increased perfusion pressure.
This is why Methyl Nicotinate is not a cosmetic add-on in the Kapyderm formula — it is the delivery mechanism that makes the rest of the ampoule work more effectively at depth.
Ampoule N is the purifying ampoule without Methyl Nicotinate. This is not a limitation — it is a deliberate formulation choice. For scalps where the primary need is clarification without microcirculation activation (sensitive scalps, home use protocols, early-phase treatment), the warming response is unnecessary and potentially uncomfortable. Ampoule N delivers the full purifying botanical complex — burdock, arnica, rosemary, salicylic acid, sulfur, eucalyptol — without vasodilation. The clinical decision between N and KN is: does this scalp need purification only, or purification plus microcirculation activation?
The Purifying Family: Ampoule N and Ampoule KN
The purifying ampoules share a botanical complex built around three complementary mechanisms: antiseptic and sebum-regulating action (burdock root, sulfur, salicylic acid), anti-inflammatory and circulatory support (arnica, rosemary), and scalp balancing (potassium iodide, eucalyptol). Their clinical role is to clear the follicular opening of accumulated sebum, oxidized byproducts and microbial overgrowth — the congestion layer that blocks active penetration and drives perifollicular micro-inflammation.
Scalps requiring purification without microcirculation activation. Home protocol use. Sensitive scalps where warming response is not appropriate. Introductory ampoule step before progressing to KN in-center. Also used when the purifying phase is indicated without the in-center activation component.
Mild herbal freshness from Eucalyptol. No warming response. No redness. Suitable for home use without specialist supervision. The Propylene Glycol in Ampoule N (not present in KN) contributes to the slightly different sensory texture between the two purifying ampoules.
In-center purifying and activation step — dandruff, seborrhea, pityriasis, alopecia areata, and scalps where microcirculation activation alongside purification is indicated. The Methyl Nicotinate component makes KN the appropriate choice when both sebum clearing and blood flow stimulation are required simultaneously.
Methyl Nicotinate warming response — visible redness and warmth at the application site, confirming vasodilation. Herbal eucalyptol finish. Unlike Ampoule N, KN does not contain Propylene Glycol. The warming response is the clinical marker that microcirculation activation has occurred.
The Nutritive Reconstruction Family: Ampoule KD and Ampoule DT
Where the purifying ampoules address the scalp environment, the nutritive ampoules address the follicle itself. KD and DT supply the structural proteins, B vitamins, hyaluronic acid and microcirculation activation that a compromised follicle bulb needs to rebuild keratin chain integrity, extend the anagen phase, and reactivate dormant growth. They are the treatment step after the scalp has been cleared — delivering concentrated nutrition into a now-accessible follicular channel.
Hair fiber reconstruction and keratin chain restructuring. Follicle bulb dysfunction. Diffuse and acute temporary hair loss. Deficiency states (nutritional, stress-related). The most complex ampoule in the line — nutritive base plus microcirculation activation. Preferred in-center formulation for nutritive protocols. Choose KD over DT for clients with fragrance sensitivities.
Methyl Nicotinate warming response plus Eucalyptol herbal fresh finish. The eucalyptol provides the characteristic cool-herbal sensation that distinguishes KD from DT. No additional fragrance allergens beyond those in the botanical base — making KD the lower-allergen choice of the two nutritive ampoules.
Same nutritive reconstruction indication as KD — hair fiber and scalp nutrition, acute/progressive/diffuse alopecia, deficiency states, insufficient blood supply to the follicle. Available in packs of 6 and 20, making DT the accessible home-protocol format of the nutritive family. Some clients prefer the menthol cooling sensation; others prefer the eucalyptol herbal finish of KD.
Methyl Nicotinate warming response followed by Menthol cooling — the dual warming-then-cooling sensation that makes DT distinctive. Contains additional preservatives (Sodium Benzoate, Potassium Sorbate, Benzyl Alcohol, Lactic Acid) and two fragrance allergens not present in KD — Linalyl Acetate and Limonene. Patch test recommended for sensitive clients.
Full Comparison Table
| Ampoule | Family | Methyl Nicotinate | Keratin + Hyaluronate | Panthenol / B vitamins | Finish | Fragrance allergens | Format |
|---|---|---|---|---|---|---|---|
| Ampoule N | Purifying | No warming | No | No | Eucalyptol (mild) | None listed | 6 or 20 packs |
| Ampoule KN | Purifying | Yes — warming | No | No | Eucalyptol | None listed | 12 × 8ml box |
| Ampoule KD | Nutritive | Yes — warming | Yes — both | Yes — B5 + B6 | Eucalyptol (herbal) | None listed | 12 × 8ml box |
| Ampoule DT | Nutritive | Yes — warming | Yes — both | Yes — B5 + B6 | Menthol (cooling) | Linalyl Acetate + Limonene | 6 or 20 packs |
How Kapyderm Compares to Kérastase and Nioxin
If you've been researching professional scalp ampoules, you've encountered Kérastase and Nioxin — the two most recognized names in the professional salon ampoule category. Both are legitimate, widely used products. The comparison below is based exclusively on publicly registered INCI ingredient lists and published clinical evidence. The goal is not to dismiss competitors but to be specific about what is and isn't in each formula — so you can make an informed decision.
Kérastase Spécifique Aminexil Cure Anti-Chute
The Kérastase flagship hair loss ampoule. Its key active is Diaminopyrimidine Oxide (Aminexil) — a molecule developed by L'Oréal that inhibits the perifollicular collagen hardening process, theoretically preventing follicles from being "choked off" by stiffening tissue. Supporting ingredients include Madecassoside (centella asiatica for scalp soothing), Rhamnose (fibroblast stimulation), Carnosine (antioxidant), and Tocopherol (Vitamin E).
What the Kérastase ampoule does not contain: Methyl Nicotinate or any other clinically documented vasodilatory active. There is no mechanism in the formula for increasing blood flow to the hair bulb at the moment of application. The anti-collagen-hardening theory behind Aminexil is the product's entire mechanism — there is no scalp purification step, no keratin reconstruction, no B vitamin complex, and no peer-reviewed vasodilation data. The formula also contains multiple EU-listed fragrance allergens: Hexyl Cinnamal, Linalool, Hydroxycitronellal, Citronellol, Geraniol.
Nioxin Scalp & Hair Treatment (System 1)
Nioxin is a professional salon system built around scalp stimulation and microcirculation support. Notably, Nioxin System 1 does contain Methyl Nicotinate — making it one of the few mainstream competitors to use the same vasodilatory active as the Kapyderm ampoule system. It also contains Niacinamide (Vitamin B3), Caffeine (mild stimulant), Biotin, and a botanical blend including green tea, nettle, and grapefruit peel extract.
What Nioxin does differently — and the limitations that matter: The Nioxin treatment is a leave-on scalp serum in a pump bottle, not an ampoule system. There is no purifying phase — no mechanism for clearing sebum, oxidized byproducts or follicular congestion before applying the active. There is no Hydrolyzed Keratin (hair fiber reconstruction), no Sodium Hyaluronate (follicle matrix support), and no B5/B6 complex with documented anagen phase extension data. Nioxin's clinical evidence is primarily consumer perception data, not peer-reviewed biomarker studies. The formula also contains Triethanolamine — a pH adjuster that raises concerns when combined with certain preservative types in the same formula.
| Feature | Kérastase Aminexil Ampoule | Nioxin System 1 Treatment | Kapyderm Ampoule KD / DT |
|---|---|---|---|
| Vasodilation active | None — no vasodilatory mechanism | Methyl Nicotinate — present | Methyl Nicotinate — prostaglandin D2 pathway, LSCI-confirmed |
| Peer-reviewed vasodilation data | None published for Aminexil on scalp blood flow | None published — Methyl Nicotinate is a minor listed ingredient | Yes — NSAID inhibition reduced MN effect by 82% (P < .01); Bunker & Dowd (1987) confirmed nicotinate response on balding scalp where minoxidil showed none |
| Scalp purification phase | No — single active (Aminexil) formula | No — no keratolytic or sebum-clearing mechanism | Yes — Ampoule N/KN: salicylic acid, sulfur, burdock, arnica purify before nutritive step |
| Hair fiber reconstruction | No Hydrolyzed Keratin | No Hydrolyzed Keratin | Yes — Hydrolyzed Keratin penetration to cortex confirmed; tensile strength maintained vs. 14.32% loss in untreated hair (Molecules, 2025) |
| Follicle matrix support | No Sodium Hyaluronate | No Sodium Hyaluronate | Yes — Sodium Hyaluronate activates CD44/AKT axis in dermal papilla cells (ScienceDirect, 2026) |
| Anagen phase extension — peer-reviewed data | No published biomarker data | No published biomarker data | Yes — D-panthenol: ALP +40%, VEGF +70%, TGF-β1 -30%, Ki67 increased, apoptosis reduced (PMC8929036) |
| EU Cosmetics Regulation compliance | EU-manufactured · Contains multiple listed fragrance allergens (Hexyl Cinnamal, Linalool, Citronellol, Geraniol) | US-formulated · Contains Triethanolamine + nitrogenating agents risk flag; Limonene present | 35+ years EU Cosmetics Regulation (EC) No 1223/2009 — 1,600+ restricted substances. KD contains no Linalyl Acetate or Limonene |
| Diagnostic protocol before use | None — retail product, no trichoscopy | None — salon system, no microscopic scalp analysis | Yes — Kapykon trichoscopy camera maps follicular environment before ampoule selection. Certified Technician of Dermotricology selects ampoule based on findings |
| Certified practitioner network (US) | Salon availability only — no credential requirement | Salon availability only — no scalp diagnosis requirement | 30+ certified Technicians of Dermotricology across 15+ states and 30+ Authorized Treatment Centers, certified by Marlen Arita — Master in Dermotricology |
Kérastase makes a well-formulated, professionally finished product. Nioxin makes a well-distributed professional system used in tens of thousands of salons. Neither is a bad product. What the comparison shows is that neither has a peer-reviewed vasodilation mechanism as the centerpiece of the formula, neither has a hair fiber reconstruction component backed by cortex penetration data, and neither has a trichoscopy-based diagnostic protocol before product selection. These are not cosmetic differences — they are structural differences in what the product is designed to address and how it knows what to address before treatment begins.
Protocol Timeline: What to Expect Week by Week
One of the most common questions in scalp ampoule research — conspicuously unanswered by most competitor content — is simply: how long does it take? Here is the honest clinical timeline for the Kapyderm ampoule protocol, based on the biological mechanisms involved.
| Phase | Timeline | What's Happening | What You Notice |
|---|---|---|---|
| Attack Phase | Weeks 1–3 Intensive — 2–3× weekly |
Scalp pH is being reset. Sebum accumulation and oxidized byproducts are being cleared from the follicular opening by the purifying ampoule (N or KN). Methyl Nicotinate begins increasing microcirculation to the hair bulb. Salicylic acid is lifting scale and improving follicle channel access. | Reduction in scalp irritation, itching and greasiness. Warming response at each application confirms vasodilation is occurring. Some clients notice initial increased shedding in Week 1–2 — this is normal: the Telogen Effluvium effect as the follicle environment resets. |
| Normalizing Phase | Weeks 4–8 Transitional — 1–2× weekly |
Follicular channel is now clear. Nutritive ampoule (KD or DT) is delivering Hydrolyzed Keratin to fiber, Sodium Hyaluronate to the dermal papilla matrix, and D-panthenol is beginning to upregulate VEGF and alkaline phosphatase — the anagen-inducing biomarkers. Hair cycle extension begins. | Shedding decreases noticeably. Scalp feels cleaner and less reactive between washes. Hair that is growing feels stronger and less prone to breakage — the keratin reinforcement effect. Some new fine hairs may be visible at the hairline by Week 6. |
| Consolidation Phase | Weeks 9–12 Maintenance — 1× weekly |
The anagen phase has been extended by D-panthenol's TGF-β1 reduction and ALP activation. Follicles that were miniaturizing have had 8–10 weeks of improved blood supply, nutrient delivery and keratin availability. The CD44/AKT pathway activated by Sodium Hyaluronate is supporting dermal papilla cell proliferation. | Visible increase in hair density and coverage. Hair diameter is measurably thicker at the root. Scalp condition is stable — pH balanced, sebum regulated. Most clients at this phase can transition to maintenance with a home protocol (Ampoule N or DT, 1× weekly) rather than returning to attack intensity. |
| Maintenance | Week 12+ Ongoing — 1× weekly or fortnightly |
Once the scalp ecosystem is stabilized — pH, microbial balance, microcirculation and perifollicular inflammation all normalized — the goal shifts from restoration to preservation. Unlike minoxidil or finasteride, the Dermotricology protocol does not create dependency: the hair does not shed when you stop. Maintenance simply preserves the environment you've built. | Hair density maintained. Seasonal shedding is reduced. Scalp remains balanced between washes. A certified Technician of Dermotricology will use Kapykon trichoscopy to confirm maintenance status and adjust protocol intensity if a new shedding trigger occurs (hormonal, stress, GLP-1 medication, etc.). |
Individual timelines vary based on the degree of follicular miniaturization at the start of treatment, the specific scalp presentation (seborrheic, hormonal, nutritional, stress-related), and protocol consistency. The timelines above represent average outcomes in clients who complete the full attack and normalizing phases. Trichoscopy at Weeks 4 and 8 allows a certified Technician of Dermotricology to adjust the phase timing based on documented follicular response — not guesswork.
Ingredient Science: The Key Actives Explained
The four ampoules collectively draw on two distinct active complexes. Understanding the science behind each key active clarifies why the formulas work the way they do.
The Purifying Complex — Shared by All Four Ampoules
Arctium Majus Root (Burdock Root)
Rich in tannins, polyphenols, mucilage and fructo-oligosaccharides. Anti-inflammatory, sebum-regulating and antibacterial — the botanical that targets the oily scalp microenvironment that feeds Malassezia overgrowth and perifollicular inflammation. Present across the entire oily scalp product range in the Dermotricology line (Oily Hair Wash, KS115, Ampoule N and KN) — confirming its role as the sebum-regulation anchor botanical in the Kapyderm system.
Arnica Montana Flower Extract
Present in all four ampoules. The primary active constituents of Arnica montana are sesquiterpene lactones — principally helenalin. A peer-reviewed study (PMID 9348104) identified the core molecular mechanism: helenalin selectively inhibits activation of transcription factor NF-κB, a key regulator of the inflammatory response. NF-κB is directly implicated in the perifollicular micro-inflammation cascade that drives follicular miniaturization in androgenetic alopecia — making arnica's NF-κB inhibition clinically relevant, not just traditionally assumed.
Two significant 2024–2025 studies extend the evidence further. A 2024 study in the Journal of Ethnopharmacology (Verre et al.) confirmed helenalin significantly reduces TNF-α, IL-6, COX-2 and reactive oxygen species in inflamed macrophages — quantifying exactly which pro-inflammatory markers are suppressed. A landmark 2025 transcriptomic study from Heidelberg University (Frontiers in Immunology, Berschneider et al., PMC12568507) used nCounter gene expression analysis on primary human T cells and confirmed that Arnica extracts inhibit T cell activation and proliferation via differential NFκB and NFAT pathway suppression — with helenalin confirmed as the primary active compound responsible. This is the most mechanistically detailed human-cell-level Arnica immunomodulation study published to date.
Additionally, thymol constituents in arnica act as vasodilators of subcutaneous blood capillaries, contributing to the circulatory support component that complements Methyl Nicotinate in the three warming ampoules.
Rosmarinus Officinalis (Rosemary Leaf Extract)
The most clinically validated botanical for scalp microcirculation and hair growth in the peer-reviewed literature. A 2015 randomized comparative trial (Panahi et al., Skinmed) in 100 patients with androgenetic alopecia found rosemary oil produced comparable improvement in hair density to minoxidil 2% at 6 months — with significantly less scalp itching in the rosemary group, which matters for long-term adherence.
A 2025 prospective double-blind, three-arm, placebo-controlled RCT (Patel et al., PMC12256010, registered CTRI/2024/07/070860) enrolled 90 participants over 90 days and measured outcomes using phototrichography — objective, reproducible data. Results: hair growth rate improved 57.73% in the rosemary-lavender group; hair thickness increased nearly 70%; density improved 32%; hair loss reduced by more than 40%. Both rosemary groups significantly outperformed the coconut oil control.[5b]
A 2025 narrative review in the Journal of Advanced Trends in Medical Research confirmed rosemary benefits androgenetic alopecia, alopecia areata and central centrifugal cicatricial alopecia (CCCA) through improved vascularity, anti-inflammatory activity and antioxidant effects. Mechanistically, rosemary's 1,8-cineol (eucalyptol) stimulates microcapillary perfusion in the scalp dermis, while ursolic acid provides 5-alpha reductase inhibitory activity at the follicle level. Present in all four ampoules — its circulatory and anti-inflammatory action complements Methyl Nicotinate's prostaglandin-mediated vasodilation in KN, KD and DT.
Salicylic Acid + Sulfur + Potassium Iodide
The keratolytic and scalp-balancing trio present in the purifying ampoules (N and KN) and carried forward into the nutritive ampoules (KD and DT). Salicylic acid is a beta-hydroxy acid with confirmed keratolytic and mild anti-inflammatory properties — it lifts and dissolves scale and oxidized sebum debris at the follicular opening, clearing the congestion that blocks active penetration and drives Malassezia-mediated perifollicular inflammation. A January 2025 prospective cohort study in the Journal of Cosmetic Dermatology of 20 patients with moderate-to-severe seborrheic dermatitis treated with salicylic acid achieved 80% overall clinical improvement at 4 weeks, with dandruff scores dropping from 2.45 to 1.10 and greasiness from 2.60 to 1.40 (all P < .01).[6b] This directly validates the mechanism at the center of the Ampoule N and KN clinical indication — seborrheic scalp conditions where purification is the primary therapeutic need. Sulfur provides complementary sebum balance and antimicrobial action; Potassium Iodide contributes additional purifying activity.
The Nutritive Reconstruction Complex — KD and DT Only
Hydrolyzed Keratin
Keratin is the primary structural protein of hair — comprising approximately 90% of the hair fiber. In androgenetic alopecia and stress-related hair loss, keratin chain integrity is progressively compromised. Hydrolyzed keratin is broken down into smaller peptides that have been confirmed in two independent published studies to penetrate the hair fiber at depth:
A 2021 study in the International Journal of Cosmetic Science (Malinauskyte et al., PMC7820954) showed that mid-range molecular weight keratin peptides penetrate deeper into the hair cortex than high-MW fractions, producing measurable partial hair strength recovery in damaged hair — confirmed across multiple independent research groups studying bleached Caucasian and relaxed textured hair.[2]
A March 2025 study in Molecules (MDPI, PMC11902160) confirmed via SEM and fluorescent penetration experiments that hydrolyzed keratin deposits onto the hair cuticles to form a protective film while also partially penetrating into the cortex. Key finding: tensile strength was maintained in hydrolyzed keratin-treated hair after UV radiation, while untreated hair lost 14.32% tensile strength under the same conditions — demonstrating the structural reinforcement mechanism in real-world damage conditions.[2b]
Sodium Hyaluronate
The sodium salt form of hyaluronic acid — the water-binding glycosaminoglycan naturally present in the dermal matrix surrounding the hair follicle. The evidence base for hyaluronic acid at the follicle level has expanded significantly through 2024–2026:
A 2021 in vitro study on human follicle dermal papilla cells (HFDPCs) demonstrated that non-crosslinked hyaluronic acid restored cell viability against UVB-induced cytotoxicity and produced a measurable increase in VEGF secretion — directly supporting angiogenesis and follicle blood supply.[3] A 2024/2026 study in ScienceDirect identified that medium-molecular-weight hyaluronic acid (268.1 kDa) is the most bioactive fraction for hair follicle regeneration, activating the CD44/AKT axis to drive endogenous ROS production and β-catenin stabilization in dermal papilla cells — enhancing proliferation, migration and growth factor secretion.[3b]
Together these studies confirm that the Sodium Hyaluronate in Ampoules KD and DT is not a passive humectant — it is an active signal molecule in the follicle's dermal papilla microenvironment, with documented effects on the cell-signaling pathways that govern whether the follicle remains in the anagen phase.
Panthenol + Calcium Pantothenate (Vitamin B5)
Dexpanthenol (D-panthenol) is the precursor of Vitamin B5 (pantothenic acid). A peer-reviewed study published in Cosmetics (MDPI, PMC8929036) demonstrated the following in cultured human dermal papilla cells (hDPCs) and outer root sheath cells (hORSCs):[4]
• Enhanced cell viability, increasing the proliferation marker Ki67 in cultured hDPCs
• Significantly reduced apoptosis markers Caspase3/9 and cell senescence markers p21/p16 — normally elevated in aged or resting-phase follicles
• Stimulated anagen-inducing factors: alkaline phosphatase (ALP) activity increased by 40%, β-catenin and versican activated — all markers that trigger or elongate the anagen phase
• Reduced TGF-β1 expression by 30% at both mRNA and protein levels — TGF-β1 is the growth factor that accelerates the anagen-to-catagen transition
• Upregulated VEGF expression by 70% in hDPCs — and upregulated both VEGF and its receptor VEGFR in outer root sheath cells, supporting the entire capillary delivery chain that feeds the follicle
These mechanisms — anti-apoptotic, anti-senescence, anagen-inducing and pro-angiogenic — collectively position D-panthenol as one of the most comprehensively evidenced topical actives for anti-hair loss treatment in peer-reviewed dermatology science.
Pyridoxine HCl (Vitamin B6)
Pyridoxine (B6) is a required cofactor for amino acid metabolism — the metabolic process that produces the cysteine, methionine and glycine building blocks of keratin. B6 deficiency directly impairs keratin synthesis capacity in the follicle. In the Kapyderm nutritive ampoules, Pyridoxine HCl works in concert with Panthenol and Hydrolyzed Keratin to address the nutritive deficit from three angles: external protein supply (Hydrolyzed Keratin), endogenous synthesis support (B6 as cofactor), and anagen phase extension (Panthenol via VEGF and alkaline phosphatase upregulation).
Cinchona Succirubra + Tussilago Farfara + Achillea Millefolium
Cinchona Succirubra (quinine bark) has a long documented tradition in hair loss tonic formulations for its toning and circulatory properties. Tussilago Farfara (coltsfoot) leaf extract contributes soothing and scalp-conditioning action. Achillea Millefolium (yarrow) brings anti-inflammatory, astringent and scalp-balancing properties. Together with Arnica and Burdock from the purifying base, these botanicals form the multi-action traditional complex that gives the Kapyderm nutritive ampoules their distinctive phyto-clinical character — distinguishing them from single-active pharmaceutical ampoule competitors.
Methyl Nicotinate — The Active in Three of Four Ampoules
Present in KN, KD and DT. As detailed in the mechanism section above, MN triggers local scalp vasodilation via the prostaglandin D2 pathway — confirmed by published clinical research using laser speckle contrast imaging.[1] The prostaglandin pathway's relevance to hair follicle biology was further reinforced by a 2025 Frontiers in Physiology study (Miranda et al., PMC12213377) which confirmed that Prostaglandin F2α directly stimulates growth of intermediate (miniaturized) hair follicles in ex vivo organ culture — establishing that prostaglandin-mediated signaling is a genuine hair follicle growth pathway, not only a vascular one.
In the nutritive ampoules (KD and DT), MN serves a dual purpose: first, it confirms that microcirculation to the follicle has been activated; second, it provides the vascular delivery mechanism that drives the Hydrolyzed Keratin peptides, Sodium Hyaluronate, Panthenol and B vitamins deeper into the follicular channel than passive diffusion allows. Cannot claim "plant-based" — Methyl Nicotinate is a synthetic ester.
Protocol Placement: How the Ampoules Fit the Full Dermotricology System
In the Kapyderm Dermotricology protocol developed by Marlen Arita, Master in Dermotricology, the ampoule step always follows the cleansing base — the Kapyderm Hair Loss Wash or appropriate cleansing base for the scalp type. The cleansing base resets scalp pH (target: 5.0–5.5) and removes the bulk of surface accumulation. For attack-phase protocols, the Organic Turba (Peat Mask) may precede the ampoule step as a deep-follicular clearing treatment before the active is applied.
Step 1: Cleansing Base (appropriate wash for scalp type — Hair Loss, Normalising, Dandruff, Oily or Dry) → pH reset, surface removal
Step 2 (attack phase): Organic Turba Mask — 20 minutes, emulsified and rinsed → deep follicular clearing
Step 3: Ampoule (N, KN, KD or DT — selected based on trichoscopy findings) → applied to clean, dry scalp. Leave on. Do not rinse.
Step 4: Tonic (Base, Alogenic, K1, K2, KS115, Fungi Activ or Seboregulator — based on scalp type) → secondary leave-on active layer
Step 5 (if indicated): Balsamic Collagen Emulsion or Special K Cream → conditioning or moisturizing finish
The ampoule selection logic at Step 3 follows this clinical decision tree:
- Dandruff, seborrhea, pityriasis, alopecia areata (in-center): Ampoule KN — purification plus microcirculation activation
- Purification needed, no warming response appropriate (home use, sensitive scalp): Ampoule N — purifying complex without vasodilation
- Hair fiber reconstruction, diffuse or acute hair loss, nutritional deficiency states (in-center, fragrance-sensitive client): Ampoule KD — nutritive complex, Eucalyptol finish, no Linalyl Acetate or Limonene
- Hair fiber reconstruction, diffuse or acute hair loss (home protocol or client who prefers cooling sensation): Ampoule DT — same nutritive complex, Menthol cooling finish, available in home-use pack sizes
Full protocol guidance — attack, normalizing and maintenance phase ampoule sequencing, layering with tonics, combined purifying and nutritive protocols, and Kapykon trichoscopy imaging interpretation — is available through the Kapyderm USA Professionals Portal.
Ampoule selection should always be preceded by Kapykon trichoscopy mapping. The trichoscopy findings determine not only which ampoule is indicated but also the phase intensity: whether a full attack-phase Turba + KN protocol is appropriate, or whether a normalized maintenance protocol using N or DT is the correct sequence for this client at this stage. Protocol decisions made without trichoscopy data are protocol decisions made without diagnosis.
Not yet certified? Become a Kapyderm USA Authorized Treatment Center — certified training by Marlen Arita, Master in Dermotricology, with territory protection across the U.S.
Frequently Asked Questions
- Elawa, S., et al. (2020). Skin blood flow response to topically applied methyl nicotinate: Possible mechanisms. Skin Research and Technology. PMID: 31777124. doi:10.1111/srt.12807 — NSAID inhibition reduced MN-induced perfusion increase by 82% (P < .01); nerve pathway inhibition by 32% (P < .01).
- Oxford Academic / Laboratory Medicine. (2022). Topical application of methyl nicotinate solution enhances peripheral blood collection — nicotinic acid derivatives stimulate mast cells to release prostaglandin D2, inducing vasodilation and blood flow. doi:10.1093/labmed/lmac005
- Bunker, C. B., & Dowd, P. M. (1987). Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia. British Journal of Dermatology, 117(5), 668–669. PMID: 3689690 — no significant scalp blood flow change with 3% minoxidil; positive response to 0.1% hexyl nicotinate.
- Malinauskyte, E., et al. (2021). Penetration of different molecular weight hydrolysed keratins into hair fibres and their effects on the physical properties of textured hair. International Journal of Cosmetic Science, 43(1). PMC7820954.
- Bian, X., et al. (2025). Performance and mechanism of hydrolyzed keratin for hair photoaging prevention. Molecules, 30(5), 1182. PMC11902160. doi:10.3390/molecules30051182 — SEM and fluorescent penetration confirmed cortex penetration; tensile strength maintained vs. 14.32% decline in untreated hair.
- Zerbinati, N., et al. (2021). In vitro hair growth promoting effect of a noncrosslinked hyaluronic acid in human dermal papilla cells. BioMed Research International. PMC8572598. doi:10.1155/2021/5598110 — increased VEGF secretion; restored cell viability against UVB cytotoxicity.
- Liu, J., et al. (2026). Medium-molecular weight hyaluronic acid orchestrates hair follicle regeneration via CD44/AKT-driven endogenous ROS activation of β-catenin. ScienceDirect. doi:10.1016/j.ijbiomac.2026.016788 — medium MW HA (268.1 kDa) most bioactive; activates CD44/AKT axis and β-catenin in human dermal papilla cells.
- Kim, J. E., et al. (2022). Dexpanthenol promotes cell growth by preventing cell senescence and apoptosis in cultured human hair follicle cells. Cosmetics, 9(3), 97. PMC8929036. doi:10.3390/cosm9030097 — ALP +40%, VEGF +70%, TGF-β1 -30%, Ki67 increased, apoptosis markers Caspase3/9 reduced, VEGFR upregulated in outer root sheath cells.
- Salehi, B., et al. (2024). Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-κB. PMID: 9348104 — molecular mechanism of arnica's anti-inflammatory effect confirmed at transcription factor level.
- Panahi, Y., et al. (2015). Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed — comparable hair count increase at 6 months; significantly less scalp itching in rosemary group. Confirmed by 2025 90-participant registered clinical trial.
- Springer Nature. (2024). Harnessing the power of Arctium lappa root: A review of its pharmacological properties and therapeutic applications. Natural Products and Bioprospecting. doi:10.1007/s13659-024-00466-8
- Ge, Y., et al. (2025). A cohort clinical study on the efficacy of topical salicylic acid in improving symptoms of moderate to severe seborrheic dermatitis of the scalp. Journal of Cosmetic Dermatology. PMC11705510. doi:10.1111/jocd.16742 — 80% overall clinical improvement at 4 weeks; dandruff 2.45→1.10, greasiness 2.60→1.40 (all P < .01).
- Economopoulos, V. (2026). Scalp microbiome alterations in androgenetic alopecia: Patterns and emerging mechanistic insights. International Journal of Dermatology, 1–10. doi:10.1111/ijd.70365
Experience the ampoule system with a certified Dermotricologist.
Ampoule selection is most effective when preceded by trichoscopy. Find a certified Technician of Dermotricology near you, explore the at-home protocol, or bring the Kapyderm system to your practice.
